EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer
暂无分享,去创建一个
V. LeBleu | R. Kalluri | Chia-Chin Wu | Xiaofeng Zheng | Jiha Kim | Valerie S. LeBleu | Julienne L. Carstens | H. Sugimoto | Matthew Scheible | J. Carstens | Judith Kaye
[1] M. Korc,et al. Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation. , 2016, The Journal of clinical investigation.
[2] Umar Mahmood,et al. Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival. , 2015, Cancer cell.
[3] Christian Pilarsky,et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer , 2015, Nature.
[4] Melissa J. Davis,et al. Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines , 2015, Cell Communication and Signaling.
[5] Melissa J. Davis,et al. Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines , 2015, Cell Communication and Signaling.
[6] R. Kalluri,et al. Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2. , 2015, Cell reports.
[7] M. Loda,et al. Combined MEK and PI3K Inhibition in a Mouse Model of Pancreatic Cancer , 2014, Clinical Cancer Research.
[8] T. Seufferlein,et al. Smarter drugs emerging in pancreatic cancer therapy. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] B. Bao,et al. Activated K‐Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype , 2013, Journal of cellular physiology.
[10] D. Newgreen,et al. Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells , 2013, Breast Cancer Research.
[11] Jing Yang,et al. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. , 2012, Cancer cell.
[12] R. Hruban,et al. Human Correlates of Provocative Questions in Pancreatic Pathology , 2012, Advances in anatomic pathology.
[13] Gerald C. Chu,et al. Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.
[14] Maximilian Reichert,et al. EMT and Dissemination Precede Pancreatic Tumor Formation , 2012, Cell.
[15] Jason Y. Park,et al. Pdx1 Expression in Pancreatic Precursor Lesions and Neoplasms , 2011, Applied immunohistochemistry & molecular morphology : AIMM.
[16] Yan Tao,et al. Knockdown of Snail Sensitizes Pancreatic Cancer Cells to Chemotherapeutic Agents and Irradiation , 2010, International journal of molecular sciences.
[17] Jennifer A. Prescher,et al. Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models , 2010, Proceedings of the National Academy of Sciences.
[18] Kakajan Komurov,et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes , 2010, Proceedings of the National Academy of Sciences.
[19] T. Hibi,et al. Solitary cell infiltration is a novel indicator of poor prognosis and epithelial-mesenchymal transition in pancreatic cancer. , 2010, Human pathology.
[20] 眞杉 洋平. Solitary cell infiltration is a novel indicator of poor prognosis and epithelial-mesenchymal transition in pancreatic cancer , 2010 .
[21] Julia Schüler,et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs , 2009, Nature Cell Biology.
[22] Huamin Wang,et al. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. , 2009, Cancer research.
[23] Raghu Kalluri,et al. The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.
[24] Zhiwei Wang,et al. Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. , 2009, Cancer research.
[25] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[26] G. Gallick,et al. Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells , 2007, Annals of Surgical Oncology.
[27] T. Khoury,et al. Epithelial-Mesenchymal Transition (EMT) and Activated Extracellular Signal-regulated Kinase (p-Erk) in Surgically Resected Pancreatic Cancer , 2007, Annals of Surgical Oncology.
[28] H. Buhr,et al. Epithelial to Mesenchymal Transition: Expression of the Regulators Snail, Slug, and Twist in Pancreatic Cancer , 2007, Clinical Cancer Research.
[29] Chun-you Wang,et al. Expression of snail in pancreatic cancer promotes metastasis and chemoresistance. , 2007, The Journal of surgical research.
[30] J. Davis. Bioinformatics and Computational Biology Solutions Using R and Bioconductor , 2007 .
[31] H. Moses,et al. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression. , 2006, Genes & development.
[32] R. Hruban,et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.
[33] Carlos L Arteaga,et al. Dual role of transforming growth factor beta in mammary tumorigenesis and metastatic progression. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[34] Gordon K. Smyth,et al. limma: Linear Models for Microarray Data , 2005 .
[35] S. Ramaswamy,et al. Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.
[36] I. Fabregat,et al. Snail blocks the cell cycle and confers resistance to cell death. , 2004, Genes & development.
[37] Eduard Batlle,et al. Snail Induction of Epithelial to Mesenchymal Transition in Tumor Cells Is Accompanied by MUC1 Repression andZEB1 Expression* , 2002, The Journal of Biological Chemistry.
[38] R. Foisner,et al. E-cadherin regulates cell growth by modulating proliferation-dependent β-catenin transcriptional activity , 2001, The Journal of cell biology.
[39] B. Hogan,et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. , 1996, Development.
[40] J. Garland. The New England Journal of Medicine. , 1961, Canadian Medical Association journal.